Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription 05.07.2021 1 Am J Clin Oncol 1 Am J Respir Crit Care Med 1 Ann Oncol 1 Ann Surg Oncol 3 Ann Thorac Surg 1 Arch Bronconeumol 1 BMC Cancer 1 Cancer Epidemiol Biomarkers Prev 2 Carcinogenesis 1 Chest 1 Clin Exp Metastasis 1 Clin Lung Cancer 1 Clin Nucl Med 1 Eur J Cancer 9 Eur J Cardiothorac Surg 3 Eur Respir J 3 Int J Radiat Oncol Biol Phys 8 J Thorac Cardiovasc Surg 2 JAMA Oncol 1 Lung Cancer 3 Oncol Rep 2 Oncologist 3 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. MORTMAN KD, Devlin J, Giang B, Mortman R, et al
   Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program.
   Am J Clin Oncol. 2021;44:264-268.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

2. KRISTO S, Zou T, Dexter EU, Pokharel S, et al
   Amyloid Nodules Masquerading as Multifocal Lung Cancer.
   Am J Respir Crit Care Med. 2021 Jun 25. doi: 10.1164/rccm.202010-3756.
   PubMed        
   
   

   
   Ann Oncol

3. RODRIGUEZ-ABREU D, Powell SF, Hochmair MJ, Gadgeel S, et al
   Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.
   Ann Oncol. 2021;32:881-895.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. KIM IA, Kim WS, Lee KY
   ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
   Ann Surg Oncol. 2021;28:3994-3995.
   PubMed        
   
   

   
   Ann Thorac Surg

5. SPICER JD
   The case for peri-adjuvant therapy in early-stage lung cancer.
   Ann Thorac Surg. 2021 Jun 29. pii: S0003-4975(21)01073.
   PubMed        
   
   
6. TSUTANI Y, Imai K, Ito H, Miyata Y, et al
   Adjuvant chemotherapy for high-risk pathological stage I non-small cell lung cancer.
   Ann Thorac Surg. 2021 Jun 26. pii: S0003-4975(21)01057.
   PubMed         Abstract available
   
   
7. CASIRAGHI M, Spaggiari L
   22-Year Disease-Free Survival After Extended Pulmonary Metastasectomy: The Evidence of Success.
   Ann Thorac Surg. 2021;111:2091.
   PubMed        
   
   

   
   Arch Bronconeumol

8. ROUSSEL L, Brindel A, Pouget C, Treffel G, et al
   Pleural Effusion Occurring During Lung Cancer Immunotherapy: A Challenge for the Clinician.
   Arch Bronconeumol. 2021 Jun 4. pii: S0300-2896(21)00177.
   PubMed        
   
   

   
   BMC Cancer

9. CHRISTOPOULOS P, Bozorgmehr F, Bruckner L, Chung I, et al
   Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial.
   BMC Cancer. 2021;21:743.
   PubMed         Abstract available
   
   

   
   Cancer Epidemiol Biomarkers Prev

10. ABE SK, Narita S, Saito E, Sawada N, et al
    Body mass index, height, weight change, and subsequent lung cancer risk: the Japan Public Health Center-based Prospective Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 25. pii: 1055-9965.EPI-21-0195.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

11. HAMADA K, Tian Y, Fujimoto M, Takahashi Y, et al
    DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
    Carcinogenesis. 2021;42:169-179.
    PubMed         Abstract available
    
    
12. LI P, Zhang X, Murphy AJ, Costa M, et al
    Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
    Carcinogenesis. 2021;42:136-147.
    PubMed         Abstract available
    
    

    
    Chest

13. FOX AH, Jett JR, Roy UB, Johnson BE, et al
    Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer.
    Chest. 2021 Jun 25. pii: S0012-3692(21)01253-8. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

14. FIORENTINO F, Treasure T
    Is survival really better after repeated lung metastasectomy?
    Clin Exp Metastasis. 2021;38:73-75.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

15. LI Y, Zhang Y, Jia X, Jiang P, et al
    Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non-Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2021 May 28. pii: S1525-7304(21)00098.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

16. HORN KP, Thomas HMT, Vesselle HJ, Kinahan PE, et al
    Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Clin Nucl Med. 2021 Jun 25. pii: 00003072-900000000-95969.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

17. AHN BC, So JW, Synn CB, Kim TH, et al
    Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer.
    Eur J Cancer. 2021;153:179-189.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

18. WANG Z, Yang H, Hao X, Zhou J, et al
    Prognostic significance of the N1 classification pattern: a meta-analysis of different subclassification methods.
    Eur J Cardiothorac Surg. 2021;59:545-553.
    PubMed         Abstract available
    
    
19. KAMIGAICHI A, Tsutani Y, Okada M
    Reply to Zhang et al.
    Eur J Cardiothorac Surg. 2021;59:928.
    PubMed        
    
    
20. VAN RAEMDONCK D, Treasure T, Van Cutsem E, Macbeth F, et al
    Pulmonary Metastasectomy in Colorectal Cancer: has the randomized controlled trial brought enough reliable evidence to convince believers in metastasectomy to reconsider their oncological practice?
    Eur J Cardiothorac Surg. 2021;59:517-521.
    PubMed        
    
    
21. CHENESSEAU J, Mitilian D, Sharma G, Mussot S, et al
    Superior vena cava prosthetic replacement for non-small cell lung cancer: is it worthwhile?
    Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6312872. doi: 10.1093.
    PubMed         Abstract available
    
    
22. XIE D, Wu J, Hu X, Gonzalez-Rivas D, et al
    Uniportal versus multiportal video-assisted thoracoscopic surgery does not compromise the outcome of segmentectomy.
    Eur J Cardiothorac Surg. 2021;59:650-657.
    PubMed         Abstract available
    
    
23. CASIRAGHI M, Spaggiari L
    Reply to Lampridis.
    Eur J Cardiothorac Surg. 2021;59:926-927.
    PubMed        
    
    
24. NAKAGAWA K
    Reply to Ding et al.
    Eur J Cardiothorac Surg. 2021;59:925-926.
    PubMed        
    
    
25. ZHONG Y, Xu Y, Deng J, Wang T, et al
    Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2021;59:624-632.
    PubMed         Abstract available
    
    
26. YANG H, Mei T
    The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
    Eur J Cardiothorac Surg. 2021 Jul 1. pii: 6311990. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur Respir J

27. FERNANDES S, Williams G, Williams E, Ehrlich K, et al
    Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.
    Eur Respir J. 2021;57.
    PubMed         Abstract available
    
    
28. HASANI AM, Matthew B, Goljamali M, Chen YC, et al
    Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study.
    Eur Respir J. 2021;57.
    PubMed        
    
    
29. MALDONADO F, Varghese C, Rajagopalan S, Duan F, et al
    Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.
    Eur Respir J. 2021;57.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

30. HELM A, Tinganelli W, Simoniello P, Kurosawa F, et al
    Reduction of Lung Metastases in a Mouse Osteosarcoma Model Treated With Carbon Ions and Immune Checkpoint Inhibitors.
    Int J Radiat Oncol Biol Phys. 2021;109:594-602.
    PubMed         Abstract available
    
    
31. SOYFER V, Gutfeld O, Shamai S, Schlocker A, et al
    COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
    Int J Radiat Oncol Biol Phys. 2021;110:957-961.
    PubMed         Abstract available
    
    
32. NAM JK, Kim AR, Choi SH, Kim JH, et al
    Pharmacologic Inhibition of HIF-1alpha Attenuates Radiation-Induced Pulmonary Fibrosis in a Preclinical Image Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:553-566.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

33. ANTONOFF MB, Morris VK
    Reply from author: Biology is king, but metastasectomy still has a role for properly selected patients.
    J Thorac Cardiovasc Surg. 2021;162:e136-e138.
    PubMed        
    
    
34. CAMERON RB
    Reply: Discussions regarding pulmonary metastasectomy are similar to American politics: Both are extremely polarizing, unsatisfying, inconclusive, and undertaken at your own peril.
    J Thorac Cardiovasc Surg. 2021;162:e135-e136.
    PubMed        
    
    
35. WIGHTMAN SC, Kim AW
    Commentary: When less is more for lung cancers.
    J Thorac Cardiovasc Surg. 2021;161:1650-1651.
    PubMed        
    
    
36. SIHAG S
    Commentary: Sarcomas and sarcomatoid tumors of the lung...not your average lung cancers.
    J Thorac Cardiovasc Surg. 2021;162:285-286.
    PubMed        
    
    
37. CERFOLIO RJ
    Commentary: Let us raise the bar higher for better patient outcomes.
    J Thorac Cardiovasc Surg. 2021;161:1649-1650.
    PubMed        
    
    
38. WEKSLER B, Sullivan JL, Schumacher LY
    Randomized trial of bupivacaine with epinephrine versus bupivacaine liposome suspension in patients undergoing minimally invasive lung resection.
    J Thorac Cardiovasc Surg. 2021;161:1652-1661.
    PubMed         Abstract available
    
    
39. HIRPARA DH, Kidane B
    Commentary: VATS, RATS, stats, and some caveats.
    J Thorac Cardiovasc Surg. 2021;162:269-270.
    PubMed        
    
    
40. WANG SX, Marshall MB
    Commentary: A new hope: Do ADAURA trial results change the paradigm for treatment of resectable lung adenocarcinoma?
    J Thorac Cardiovasc Surg. 2021;162:293-294.
    PubMed        
    
    

    
    JAMA Oncol

41. TAKSLER GB, Peterse EFP, Willems I, Ten Haaf K, et al
    Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    JAMA Oncol. 2021;7:885-894.
    PubMed         Abstract available
    
    
42. BARTELS F, Wandrey MM, Aigner A, Stronisch T, et al
    Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
    JAMA Oncol. 2021 Jul 1. pii: 2781389. doi: 10.1001/jamaoncol.2021.2049.
    PubMed         Abstract available
    
    

    
    Lung Cancer

43. SU PL, Tsai JS, Yang SC, Wu YL, et al
    Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment.
    Lung Cancer. 2021;158:137-145.
    PubMed         Abstract available
    
    

    
    Oncol Rep

44. HE Q, Dong Y, Zhu Y, Ding Z, et al
    TMEM100 induces cell death in nonsmall cell lung cancer via the activation of autophagy and apoptosis.
    Oncol Rep. 2021;45.
    PubMed         Abstract available
    
    
45. ZHANG X, He Y, Jiang Y, Bao Y, et al
    TMEM229A suppresses nonsmall cell lung cancer progression via inactivating the ERK pathway.
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    
46. LU R, Zhou Q, Ju L, Chen L, et al
    Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    

    
    Oncologist

47. TJONG MC, Doherty M, Tan H, Chan WC, et al
    Province-Wide Analysis of Patient Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
    Oncologist. 2021 Jul 3. doi: 10.1002/onco.13890.
    PubMed         Abstract available
    
    
48. GRAY J, Thompson JC, Carpenter EL, Elkhouly E, et al
    Plasma cell-free DNA genotyping-from an emerging concept to a standard-of-care tool in metastatic non-small cell lung cancer.
    Oncologist. 2021 Jul 3. doi: 10.1002/onco.13889.
    PubMed         Abstract available
    
    

    
    PLoS One

49. CHEN DT, Chan W, Thompson ZJ, Thapa R, et al
    Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
    PLoS One. 2021;16:e0252041.
    PubMed         Abstract available
    
    
50. BOROWICZ S, Principe DR, Dorman MJ, McHenry AJ, et al
    HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization.
    PLoS One. 2021;16:e0252197.
    PubMed         Abstract available
    
    
51. FUCHS J, Fruh M, Papachristofilou A, Bubendorf L, et al
    Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study.
    PLoS One. 2021;16:e0253601.
    PubMed         Abstract available
    
    

    
    Thorax

52. KRAMER T, Wijmans L, de Bruin M, van Leeuwen T, et al
    Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer.
    Thorax. 2021 Jun 25. pii: thoraxjnl-2021-216885.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: